Lise‐Lotte Gundersen

3.3k total citations
104 papers, 2.9k citations indexed

About

Lise‐Lotte Gundersen is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lise‐Lotte Gundersen has authored 104 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Organic Chemistry, 31 papers in Molecular Biology and 19 papers in Infectious Diseases. Recurrent topics in Lise‐Lotte Gundersen's work include Synthesis and Reactivity of Heterocycles (20 papers), Synthesis and Biological Evaluation (17 papers) and HIV/AIDS drug development and treatment (13 papers). Lise‐Lotte Gundersen is often cited by papers focused on Synthesis and Reactivity of Heterocycles (20 papers), Synthesis and Biological Evaluation (17 papers) and HIV/AIDS drug development and treatment (13 papers). Lise‐Lotte Gundersen collaborates with scholars based in Norway, Sweden and United States. Lise‐Lotte Gundersen's co-authors include Frode Rise, Anne Kristin Bakkestuen, Bjørn Spilsberg, Colin Charnock, Anders Vik, Ayele H. Negussie, Karl Egil Malterud, Lars Bohlin, Erik Hedner and Aalt Bast and has published in prestigious journals such as Current Biology, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Lise‐Lotte Gundersen

104 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lise‐Lotte Gundersen Norway 31 2.3k 848 486 253 238 104 2.9k
Alan D. Borthwick United Kingdom 23 1.3k 0.6× 1.1k 1.3× 385 0.8× 330 1.3× 132 0.6× 52 2.2k
Satoshi Ichikawa Japan 32 1.8k 0.8× 2.0k 2.4× 246 0.5× 610 2.4× 197 0.8× 155 3.3k
Pál Herczegh Hungary 22 1.1k 0.5× 719 0.8× 137 0.3× 182 0.7× 50 0.2× 135 1.6k
R. H. WIGHTMAN United Kingdom 26 1.5k 0.6× 1.1k 1.3× 108 0.2× 163 0.6× 87 0.4× 116 2.0k
David L. Jakeman Canada 30 1.0k 0.5× 1.3k 1.5× 106 0.2× 493 1.9× 344 1.4× 103 2.1k
Fritz Hansske Canada 20 605 0.3× 799 0.9× 271 0.6× 138 0.5× 49 0.2× 37 1.3k
Jianzhong Yao China 29 1.5k 0.7× 943 1.1× 448 0.9× 235 0.9× 44 0.2× 81 2.5k
Fumiaki Yokokawa Japan 29 908 0.4× 719 0.8× 412 0.8× 330 1.3× 273 1.1× 63 2.2k
Baojie Wan United States 34 2.1k 0.9× 1.4k 1.7× 1.0k 2.1× 252 1.0× 63 0.3× 86 3.3k
David S. Larsen New Zealand 24 783 0.3× 620 0.7× 96 0.2× 136 0.5× 117 0.5× 100 1.6k

Countries citing papers authored by Lise‐Lotte Gundersen

Since Specialization
Citations

This map shows the geographic impact of Lise‐Lotte Gundersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise‐Lotte Gundersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise‐Lotte Gundersen more than expected).

Fields of papers citing papers by Lise‐Lotte Gundersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise‐Lotte Gundersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise‐Lotte Gundersen. The network helps show where Lise‐Lotte Gundersen may publish in the future.

Co-authorship network of co-authors of Lise‐Lotte Gundersen

This figure shows the co-authorship network connecting the top 25 collaborators of Lise‐Lotte Gundersen. A scholar is included among the top collaborators of Lise‐Lotte Gundersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise‐Lotte Gundersen. Lise‐Lotte Gundersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gundersen, Lise‐Lotte, et al.. (2023). Selective C‐7 Functionalization of Phenanthridines by Microwave‐Assisted Claisen Rearrangements of 8‐Allyloxyphenanthridines. ChemistryOpen. 12(7). e202300095–e202300095. 1 indexed citations
2.
Milet‐Pinheiro, Paulo, Arthur Domingos‐Melo, Daniela Maria do Amaral Ferraz Navarro, et al.. (2020). A Semivolatile Floral Scent Marks the Shift to a Novel Pollination System in Bromeliads. Current Biology. 31(4). 860–868.e4. 17 indexed citations
3.
Petersen, Dirk, Louis Maes, An Matheeussen, et al.. (2019). Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes. Bioorganic & Medicinal Chemistry. 27(4). 620–629. 9 indexed citations
4.
Leroux, Vincent, Mats Ökvist, André van Eerde, et al.. (2012). When Inhibitors Do Not Inhibit: Critical Evaluation of Rational Drug Design Targeting Chorismate Mutase from Mycobacterium tuberculosis. Chemistry & Biodiversity. 9(11). 2507–2527. 4 indexed citations
5.
Charnock, Colin, et al.. (2011). Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles. Bioorganic & Medicinal Chemistry. 19(11). 3483–3491. 30 indexed citations
6.
Miranda, Pedro O., et al.. (2010). Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines. Bioorganic & Medicinal Chemistry. 18(11). 3885–3897. 34 indexed citations
7.
Charnock, Colin, Robert Burman, Jenny Felth, et al.. (2010). Antimicrobial and Antineoplastic Activities of Agelasine Analogs Modified in the Purine 2‐Position. Archiv der Pharmazie. 344(1). 50–55. 19 indexed citations
8.
Charnock, Colin, et al.. (2009). Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines. Bioorganic & Medicinal Chemistry Letters. 19(12). 3297–3299. 25 indexed citations
9.
Bakken, Vebjørn, et al.. (2009). Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Bioorganic & Medicinal Chemistry. 17(18). 6512–6516. 23 indexed citations
10.
Sjögren, Martin, Mia Dahlström, Erik Hedner, et al.. (2008). Antifouling activity of the sponge metabolite agelasine D and synthesised analogs onBalanus improvisus. Biofouling. 24(4). 251–258. 31 indexed citations
11.
Proszenyák, Ágnes, Colin Charnock, Erik Hedner, et al.. (2007). Synthesis, Antimicrobial and Antineoplastic Activities for Agelasine and Agelasimine Analogs with a β‐Cyclocitral Derived Substituent. Archiv der Pharmazie. 340(12). 625–634. 31 indexed citations
13.
Gundersen, Lise‐Lotte, et al.. (2006). Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. European Journal of Pharmaceutical Sciences. 30(1). 26–35. 136 indexed citations
14.
Bakkestuen, Anne Kristin, et al.. (2005). Synthesis and antimycobacterial activity of agelasine E and analogs. Organic & Biomolecular Chemistry. 3(6). 1025–1025. 62 indexed citations
15.
Bråthe, Anders, Lise‐Lotte Gundersen, Karl Egil Malterud, & Frode Rise. (2005). 6‐Substituted Purines as Inhibitors of 15‐Lipoxygenase; a Structure‐Activity Study. Archiv der Pharmazie. 338(4). 159–166. 20 indexed citations
16.
Gundersen, Lise‐Lotte, et al.. (2003). Indolizines as novel potent inhibitors of 15-Lipoxygenase. Bioorganic & Medicinal Chemistry. 11(24). 5409–5415. 70 indexed citations
17.
Gundersen, Lise‐Lotte, et al.. (2002). Cytotoxic and Antibacterial Activity of 2-Oxopurine Derivatives. Bioorganic & Medicinal Chemistry Letters. 12(4). 567–569. 61 indexed citations
18.
Gundersen, Lise‐Lotte, et al.. (2001). Synthesis of 5-Substituted Pyrrolo[1,2-b]pyridazines with Antioxidant Properties. Archiv der Pharmazie. 334(1). 21–24. 27 indexed citations
19.
Bakkestuen, Anne Kristin, et al.. (2000). 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 10(11). 1207–1210. 113 indexed citations
20.
Gundersen, Lise‐Lotte, et al.. (1998). Inhibition of lipid peroxidation mediated by indolizines. Bioorganic & Medicinal Chemistry Letters. 8(14). 1829–1832. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026